BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 149590)

  • 1. Susceptibilities of normal and malignant human lung cells in culture to the cytocidal action of antitumor agents.
    Tsukeda H; Mizuno S; Nitta K
    Cancer Res; 1978 Aug; 38(8):2529-32. PubMed ID: 149590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression.
    Giaccone G; Gazdar AF; Beck H; Zunino F; Capranico G
    Cancer Res; 1992 Apr; 52(7):1666-74. PubMed ID: 1312895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential sensitivities of five rat hepatoma cell lines to anticancer drugs.
    Barranco SC; Haenelt BR; Gee EL
    Cancer Res; 1978 Mar; 38(3):656-60. PubMed ID: 75057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
    Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice.
    Geiger T; Müller M; Monia BP; Fabbro D
    Clin Cancer Res; 1997 Jul; 3(7):1179-85. PubMed ID: 9815797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of lonidamine alone and in combination with other drugs against murine RIF-1 and human HT1080 cells in vitro.
    Ning SC; Hahn GM
    Cancer Res; 1990 Dec; 50(24):7867-70. PubMed ID: 2253227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation by squalene of the cytotoxicity of anticancer agents against cultured mammalian cells and murine tumor.
    Nakagawa M; Yamaguchi T; Fukawa H; Ogata J; Komiyama S; Akiyama S; Kuwano M
    Jpn J Cancer Res; 1985 Apr; 76(4):315-20. PubMed ID: 2408954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced DNA hypermethylation and drug resistance in human tumors.
    Nyce J
    Cancer Res; 1989 Nov; 49(21):5829-36. PubMed ID: 2790794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies.
    Mekras JA; Boothman DA; Perez LM; Greer S
    Cancer Res; 1984 Jun; 44(6):2551-60. PubMed ID: 6539164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current results and perspectives of the use of human tumor cell lines for antitumor drug screening].
    Zhukova OS; Dobrynin IaV
    Vopr Onkol; 2001; 47(6):706-9. PubMed ID: 11826493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential killing efficacy of twenty antitumor drugs on proliferating and nonproliferating human tumor cells.
    Drewinko B; Patchen M; Yang LY; Barlogie B
    Cancer Res; 1981 Jun; 41(6):2328-33. PubMed ID: 7237431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of melatonin on cytotoxicity of doxorubicin toward selected cell lines (human keratinocytes, lung cancer cell line A-549, laryngeal cancer cell line Hep-2).
    Fic M; Podhorska-Okolow M; Dziegiel P; Gebarowska E; Wysocka T; Drag-Zalesinska M; Zabel M
    In Vivo; 2007; 21(3):513-8. PubMed ID: 17591362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of the differential cytotoxicity of keto-C-glycosides toward normal and malignant cells.
    Bennani-Baiti IM; Lafarge-Frayssinet C; Herscovici J; Monserret R; Robbana-Barnat S; Antonakis K; Frayssinet C; Uriel J
    Anticancer Res; 1993; 13(2):467-73. PubMed ID: 8517664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An adriamycin-resistant subline is more sensitive than the parent human small cell lung cancer cell line to lonidamine.
    Kiura K; Ohnoshi T; Ueoka H; Takigawa N; Tabata M; Segawa Y; Shibayama T; Kimura I
    Anticancer Drug Des; 1992 Dec; 7(6):463-70. PubMed ID: 1337430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
    Teicher BA; Cucchi CA; Lee JB; Flatow JL; Rosowsky A; Frei E
    Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Update of human tumor clonogenic assay in carcinoma of the lung].
    Kanzawa F
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1552-9. PubMed ID: 2992395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sensitivity of antineoplastic agents in squamous cell carcinoma of the uterine cervix xenografted into nude mice].
    Kawabata M; Hosokawa H; Katoh K; Izumi R
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3058-63. PubMed ID: 2445295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro chemosensitivity of human lung cancer cell lines.
    Ruckdeschel JC; Carney DN; Oie HK; Russell EK; Gazdar AF
    Cancer Treat Rep; 1987; 71(7-8):697-704. PubMed ID: 3038314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
    Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
    Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells.
    Diasio RB; Schuetz JD; Wallace HJ; Sommadossi JP
    Cancer Res; 1985 Oct; 45(10):4900-3. PubMed ID: 3928143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.